Immune therapy tested in study of women with triple-negative breast cancer

Early data in a preliminary human study show that an experimental immune system drug is generally safe and well tolerated in women with metastatic, triple-negative breast cancer, a persistently difficult form of the disease to treat.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1bdt1BW